Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Country/Region

Topic

April 25, 2017

DoD’s plans to grant an exclusive license to pharmaceutical company Sanofi on a vaccine candidate funded by the US government to combat Zika means there’s no guarantee that the vaccine will be developed, affordable or made available for those who need it most.

April 25, 2017

NEW YORK, APRIL 26, 2017—Replacing the standard vaccines currently recommended by the World Health Organization (WHO)—most of which require refrigeration—with heat-stable versions would save money and increase protection of women, children and babies from deadly diseases like pneumonia, diarrhea, tetanus, measles and yellow fever, according to a study by Doctors Without Borders/Médecins Sans Frontiéres (MSF) and the HERMES Logistics Team (consisting of members from the Johns Hopkins Bloomberg School of Public Health and Pittsburgh Supercomputing Center at Carnegie Mellon Un

April 19, 2017

Cameroon forces refugees back, compounding the crisis

MAIDUGURI, NIGERIA/NEW YORK, APRIL 19, 2017—Violence and insecurity in Nigeria's Borno state continue to force wave upon wave of people to flee to remote towns, while Cameroon is forcibly returning refugees to the region, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today.

April 12, 2017

Doctors Without Borders/Médecins Sans Frontières (MSF) teams witness summary executions and other tactics to terrorize civilians

April 06, 2017

Less than a year after the official end of the Ebola outbreak, the Guinean health system continues to struggle.

April 05, 2017

NEW YORK, APRIL 5, 2017—A Doctors Without Borders/Médecins Sans Frontières (MSF) medical team supporting the emergency department at Bab Al Hawa Hospital in Syria's Idlib Province has confirmed that patients' symptoms are consistent with exposure to a neurotoxic agent.

April 03, 2017

DEMINING ACTIVITIES ARE URGENTLY NEEDED AS RETREATING FIGHTERS BOOBY-TRAP HOMES AND CIVILIAN AREAS

AMSTERDAM/NORTHERN SYRIA, APRIL 3, 2017—As the front lines shift in northern Syria, explosive devices and mines are having a devastating impact on civilians, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières warned in a report released today, calling for urgently needed demining activities.

March 31, 2017

NEW YORK, MARCH 31, 2017—A hospital in northern Syria that receives support from the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) was bombed on March 25, killing two people and causing severe respiratory symptoms among patients and staff, MSF said today, denouncing the attack.

March 27, 2017

First patent opposition MSF has filed in Europe aims to increase affordable access to hepatitis C drug sofosbuvir for millions

NEW YORK/ROME/GENEVA, MARCH 27, 2017—In an effort to increase access to affordable hepatitis C treatment, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) filed a patent challenge on the lifesaving hepatitis C drug sofosbuvir with the European Patent Office (EPO) today.

March 24, 2017

NEW YORK, MARCH 24, 2017—Today, World Tuberculosis Day, Doctors Without Borders/Médecins Sans Frontières’ (MSF) is urging pharmaceutical corporations, Sequella and Pfizer, to provide open access to all existing clinical data on a promising drug, sutezolid, to help accelerate the research and development of urgently needed new, lifesaving TB treatment regimes. This data, if not released, will take years and resources to replicate, further delaying new treatment options for people living with TB.

Pages